ESMO news item · 2026-09-10
Oncology research
14 Sep 2026
On 2026-09-10 ESMO (European Society for Medical Oncology) published on its official news channel an item concerning non-small cell lung cancer (NSCLC).
Original title of the item, according to ESMO: «Daraxonrasib Shows Antitumour Activity in Patients with Previously Treated Metastatic RAS-mutated NSCLC».
This page does not reproduce the text of the ESMO item: it only reports the identifying details and refers to the official source for the full content.
Note: press release, not peer-reviewed.